Skip to main content

Table 1 Baseline clinical and biochemical characteristics at first outpatient presentation to the multidisciplinary foot clinic

From: Mortality in patients with diabetic foot ulcer: a retrospective study of 513 cases from a single Centre in the Northern Territory of Australia

Parameter Total cohort (n = 513) Reference range
Age in years 55.9 ± 12.3  
Males 322 (62.8%)  
Remote areas 153 (29.2%)  
Indigenous ethnicity 247 (48.2%)  
Past Ulcers 295 (57.5%)  
Past amputations 104 (20.3%)  
Hypertension 456 (88.9%)  
Current Smoking 234 (45.7%)  
Non-compliance 334 (65.1%)  
Neuropathy 458 (90%)  
Retinopathy 213 (49.8%)  
PVD 216 (42.6%)  
Macrovascular disease 174 (33.9%)  
CKD 241 (47.4%)  
Insulin 278 (54.2%)  
Duration of ulcer > 4 weeks 259 (50.5%)  
Mid and hind foot ulcers 129 (25.5%)  
Ulcer area in cm2 2 (0.8–5)  
Wagner grade 3–4 53 (10.3%)  
Osteomyelitis 141 (35.6%)  
Subsequent amputation 263 (51.3%)  
Blood Haemoglobin (g/L) 120.0 ± 20.9 115–165
Blood WBC (count /L) 9.2 (7.3-11.2) 4.0–11.0
Plasma CRP (mg/L) 15.1 (8–40) 0.0–5.0
HbA1c (%) 9.1 ± 2.5 4.3–5.7
Plasma LDL (mmol/L) 2.2 ± 0.98 < 3.0
Plasma HDL (mmol/L) 0.91 ± 0.42 > 1.0
Serum creatinine (mmol/L) 85 (67–127) 45–90
Urine ACR (mg/mmol) 21 (3.1–142.8) < 3.5
Serum Albumin (g/L) 36.2 ± 6.1 34–45
Serum GGT (U/L) 45 (27–93) < 43
Serum ALP (U/L) 113.5 (85–151) 30–110
  1. Data are presented as count (%) or SD standard deviation, HbA1c glycated haemoglobin, LDL low density lipoprotein, HDL high density lipoprotein, ACR albumin creatinine ratio, GGT Gamma-glutamyl transferase, ALP Alkaline phosphatase